Tactile Systems Technology, Inc.
Financials
Valuation Metrics
Tactile Systems Technology, Inc.'s Market Cap is $517M. At end of 2025 it was $649M. Ranked #2714 of 3,116 in US market (top 87%), #1177 of 1,470 on NASDAQ (top 80%), #169 of 203 in Health Care Equipment & Services (top 83%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $517M | US#2,714/3,116 Sec#169/203 |
| Revenue | $350M | US#2,368/3,116 Sec#151/203 |
| Net Income | $25M | US#2,058/3,116 Sec#103/203 |
| Total Assets | $280M | US#2,925/3,116 Sec#180/203 |
| Net Assets | $224M | US#2,634/3,116 Sec#159/203 |
| Employees | 1,086 | US#1,953/3,116 Sec#131/203 |
| Value | ||
| P/E | 20.80x | US#1,204/3,116 Sec#28/203 |
| P/B | 2.31x | US#1,493/3,116 Sec#69/203 |
| PEG | 0.32x | US#457/3,116 Sec#15/203 |
| P/S | 1.48x | US#1,040/3,116 Sec#69/203 |
| EV/EBITDA | 10.46x | US#934/3,116 Sec#26/203 |
| FCF Yield | 5.17% | US#1,389/3,116 Sec#62/203 |
| Profitability | ||
| ROE | 11.11% | US#1,247/3,116 Sec#62/203 |
| ROA | 8.89% | US#566/3,116 Sec#33/203 |
| Op. Margin | 10.00% | US#1,568/3,116 Sec#78/203 |
| Revenue Growth | 17.22% | US#794/3,116 Sec#53/203 |
| Earnings Growth | 64.52% | US#406/3,116 Sec#17/203 |
| Financial Health | ||
| Debt Ratio | 24.94% | US#274/3,116 Sec#27/203 |
| Total Debt | $14M | US#2,801/3,116 Sec#181/203 |
| FCF | $27M | US#2,132/3,116 Sec#125/203 |
| Cash | $70M | US#2,426/3,116 Sec#150/203 |
| Current Ratio | 4.12x | US#559/3,116 Sec#54/203 |
| Net Debt/EBITDA | -1.26x | US#254/3,116 Sec#17/203 |
| Performance | ||
| 1Y Return | 52.16% | US#346/3,116 Sec#37/203 |
| 1M Return | 3.76% | US#687/3,116 Sec#86/203 |
| From 52W High | -39.29% | US#2,280/3,116 Sec#164/203 |
| 1Y MDD | -34.31% | US#1,609/3,116 Sec#93/203 |
| Trading | ||
| Volume | 188,283 shares | US#2,547/3,116 Sec#176/203 |
| Trading Value | $4M | US#2,600/3,116 Sec#165/203 |
| Per Share | ||
| EPS | $1.10 | US#1,642/3,116 Sec#86/203 |
| BPS | $9.92 | US#1,838/3,116 Sec#108/203 |
Company Info
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.